Shahid Pervez
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Surgery top 10%
- Epidemiology top 10%
- Molecular Biology
- Co-authors
- Naila KayaniYasmin BhurgriAsif BhurgriSheema H HasanAhmed UsmanRashida AhmedImtiaz BashirTariq Moatter
- Topics
- Lymphoma Diagnosis and Treatment (29 papers)Sarcoma Diagnosis and Treatment (19 papers)Chronic Lymphocytic Leukemia Research (16 papers)
- Journals
- SHILAP Revista de lepidopterologíaPLoS ONEBritish Journal of Cancer
- Partner nations
- PakistanKenyaUnited Kingdom
In The Last Decade
Shahid Pervez
197 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 149
- Oncology 822
- Pulmonary and Respiratory Medicine 482
- Surgery 438
- Epidemiology 412
- Molecular Biology 366
Countries citing papers authored by Shahid Pervez
This map shows the geographic impact of Shahid Pervez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shahid Pervez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shahid Pervez more than expected).
Fields of papers citing papers by Shahid Pervez
This network shows the impact of papers produced by Shahid Pervez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shahid Pervez. The network helps show where Shahid Pervez may publish in the future.
Co-authorship network of co-authors of Shahid Pervez
This figure shows the co-authorship network connecting the top 25 collaborators of Shahid Pervez. A scholar is included among the top collaborators of Shahid Pervez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shahid Pervez. Shahid Pervez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 10 | |
| 6 | 8 | |
| 7 | BRCA1 status in Pakistani breast cancer patients with moderate family history. | 8 |
| 8 | Anaplastic large cell lymphoma: the most common T-cell lymphoma in pakistan. | 3 |
| 9 | Status of HER2 amplification, polysomy 17 and histopathological features of 425 Pakistani breast cancer patients. | 5 |
| 10 | 15 | |
| 11 | 68 | |
| 12 | 56 | |
| 13 | 38 | |
| 14 | Diagnostic surgical pathology: the importance of second opinion in a developing country. | 8 |
| 15 | 10 | |
| 16 | 8 | |
| 17 | Epidermal growth factor receptor (EGFR) as a prognostic marker: an immunohistochemical study on 315 consecutive breast carcinoma patients. | 18 |
| 18 | 7 | |
| 19 | 12 | |
| 20 | 10 |
About Shahid Pervez
Shahid Pervez is a scholar working on Otorhinolaryngology, Pathology and Forensic Medicine and Oncology, having authored 204 papers that have together received 2.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (29 papers), Sarcoma Diagnosis and Treatment (19 papers) and Chronic Lymphocytic Leukemia Research (16 papers). The work is most often cited by research in Otorhinolaryngology (169 citations), Oncology (822 citations) and Periodontics (113 citations). Shahid Pervez has collaborated with scholars based in Pakistan, Kenya and United Kingdom. Frequent co-authors include Naila Kayani, Yasmin Bhurgri, Asif Bhurgri, Sheema H Hasan, Ahmed Usman, Rashida Ahmed, Imtiaz Bashir, Tariq Moatter, Farhat Abbas and Naveen Faridi. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.